European Medicines Agency

From Wikispooks
Jump to navigation Jump to search

Group.png European Medicines Agency  
(RegulatorWebsiteRdf-entity.pngRdf-icon.png
Parent organizationEuropean Union
HeadquartersAmsterdam, The Netherlands
Issued guidance that chloroquine and hydroxychloroquine were only to be used in clinical trials or emergency use programs.

COVID-19

On 1 April 2020, the European Medicines Agency (EMA) issued guidance that chloroquine and hydroxychloroquine are only to be used in clinical trials or emergency use programs.[1] On 29 May 2020, the EMA stated that patients already taking chloroquine for unrelated conditions, should continue to do so, always under the supervision of their doctor.[2]


References

  1. "COVID-19: chloroquine and hydroxychloroquine only to be used in clinical trials or emergency use programmes". European Medicines Agency (EMA). 1 April 2020. Retrieved 2 April 2020.Page Module:Citation/CS1/styles.css must have content model "Sanitized CSS" for TemplateStyles (current model is "CSS").
  2. FRANCISCO, Estela Miranda (2020-05-29). "COVID-19: reminder of the risks chloroquine and hydroxychloroquine". European Medicines Agency. Retrieved 2020-06-10.Page Module:Citation/CS1/styles.css must have content model "Sanitized CSS" for TemplateStyles (current model is "CSS").


57px-Notepad icon.png This is a page stub. Please add to it.